Zimbabwe has turned down a major American healthcare agreement valued at $367m (272 million pounds) spanning five years because of Washington's demand for confidential information.
The decision was revealed following a official document dated December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "skewed".
A government spokesperson later clarified that the US was demanding access to health data for scientific study and profit while was unwilling to share the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable task of scaling back our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has appealed for more dialogue to reach a agreement acceptable to both sides so the nation's critical HIV treatment initiative can be sustained.
Wider Context
This development comes after a comparable situation in neighbouring Kenya, where a court blocked a similar health funding agreement after concerns were filed about the security of Kenyans' health data.
Since returning to office recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had administered aid for the American government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government agreements to boost openness and responsibility.
As per statements, Sixteen nations in Africa have to date signed these new health pacts, constituting over $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy through American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to share its biological resources and data for a long time, with no corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that shared data," he stated.
"Put simply, our nation would provide the basic resources for scientific discovery without any assurance that the end products would be available to our citizens should a new disease outbreak arise."
Sovereignty and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining systems already set up through the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This framework is intended to guarantee that when a country contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome ongoing dialogue with our American counterparts on how future collaboration might be structured in a manner that honours the independence and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but suggested that negotiations need to persist considering much of the country's HIV programmes relied on international support.
"In cases where specific concerns exist, including those involving data governance or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," it added.
The situation underscores the ongoing tensions between receiving crucial foreign assistance and protecting national sovereignty in an ever more data-driven world.